-
121
-
122
Routine Surveillance of Upper Urinary Tract Imaging for Diagnosing Upper Urinary Tract Urothelial Cancer Recurrence in Patients with Nonmuscle Invasive Bladder Cancer
Published 2024-01-01“…Although routine surveillance imaging to examine upper urinary tract urothelial cancer recurrence during follow-up of nonmuscle invasive bladder cancer is recommended, its necessity remains invalidated. …”
Get full text
Article -
123
Paeoniflorin inhibits the growth of bladder carcinoma via deactivation of STAT3
Published 2018-06-01Subjects: “…bladder cancer…”
Get full text
Article -
124
-
125
Nomogram for predicting postoperative ileus after radical cystectomy and urinary diversion: a retrospective single-center study
Published 2024-12-01Subjects: Get full text
Article -
126
Transitory Spontaneous Remission of Myelodysplasia in an Elderly Man while Receiving Intravesical Bacillus Calmette-Guérin for Bladder Cancer: A Case Report and Review of the Literature
Published 2018-01-01“…Intravescial BCG is standard immunotherapy for superficial bladder cancer. We present a patient with transfusion-dependent myelodysplasia whose blood counts normalized during treatment with intravesical BCG for bladder cancer. …”
Get full text
Article -
127
Adherence to First-Line Intravesical Bacillus Calmette-Guérin Therapy in the Context of Guideline Recommendations for US Patients With High-Risk Non-muscle Invasive Bladder Cancer
Published 2024-10-01“…**Background:** Bacillus Calmette-Guérin (BCG) can reduce recurrence and delay progression among patients with high-risk non–muscle invasive bladder cancer (NMIBC), but is associated with a substantial emotional, physical, and social burden. …”
Get full text
Article -
128
Naturally Occurring Canine Invasive Urinary Bladder Cancer: A Complementary Animal Model to Improve the Success Rate in Human Clinical Trials of New Cancer Drugs
Published 2017-01-01“…Invasive urinary bladder cancer (invasive urothelial carcinoma (InvUC)) in dogs, for example, closely mimics the cancer in humans in pathology, molecular features, biological behavior including sites and frequency of distant metastasis, and response to chemotherapy. …”
Get full text
Article -
129
Differential Role of NKG2A/HLA-E Interaction in the Outcomes of Bladder Cancer Patients Treated with <i>M. bovis</i> BCG or Other Therapies
Published 2025-01-01Subjects: “…bladder cancer…”
Get full text
Article -
130
Evaluation of the association between lymph node ratio and long-term survival in patients after surgery for lymph node-positive bladder cancer: a SEER population-based study with external validation
Published 2025-01-01Subjects: “…Lymph node-positive bladder cancer…”
Get full text
Article -
131
Understanding the long‐term impact of the COVID‐19 pandemic on non‐muscle‐invasive bladder cancer outcomes: 12‐Month follow‐up data from the international, prospective COVIDSurg Cancer study
Published 2024-11-01Subjects: “…bladder cancer…”
Get full text
Article -
132
Immunohistochemistry‐based molecular subtypes of urothelial carcinoma derive different survival benefit from platinum chemotherapy
Published 2025-01-01Subjects: “…bladder cancer…”
Get full text
Article -
133
New Trends and Future Perspectives in the Diagnosis of Urothelial Carcinoma: A Comprehensive Review of the Literature
Published 2025-01-01Subjects: Get full text
Article -
134
Combining a Risk Factor Score Designed From Electronic Health Records With a Digital Cytology Image Scoring System to Improve Bladder Cancer Detection: Proof-of-Concept Study
Published 2025-01-01“… BackgroundTo reduce the mortality related to bladder cancer, efforts need to be concentrated on early detection of the disease for more effective therapeutic intervention. …”
Get full text
Article -
135
Comparison of BCG Tokyo172 Strain Induction Therapy Between Low Dose and Standard Dose for Non-Muscle Invasive Bladder Cancer: Intravesical Instillation of BCG Tokyo172 Strain
Published 2025-01-01Subjects: “…non-muscle invasive bladder cancer…”
Get full text
Article -
136
-
137
ZNF652-Induced circRHOT1 Promotes SMAD5 Expression to Modulate Tumorigenic Properties and Nature Killer Cell-Mediated Toxicity in Bladder Cancer via Targeting miR-3666
Published 2021-01-01“…Bladder cancer (BC) is the 9th most frequent diagnosed tumor and the 2nd most common urology tumor worldwide. …”
Get full text
Article -
138
Retrospective, Non-Interventional, Multicenter Study on the Effectiveness and Safety of Intravesical Bacillus Calmette–Guerin in Patients with Non-Muscle-Invasive Bladder Cancer: Real-World Experience from Six Hospital Centers in Greece
Published 2024-12-01“…Background: While the clinical application of SII-ONCO-Bacillus Calmette–Guerin (BCG) for non-muscle-invasive bladder cancer (NMIBC) is well established in Greece, there is a lack of real-world data on its effectiveness and safety. …”
Get full text
Article -
139
The impact of preoperative venous thromboembolism on patients undergoing TURBT: Perioperative outcomes and healthcare costs from US insurance claims data
Published 2025-01-01Subjects: “…bladder cancer…”
Get full text
Article -
140
Histopathologic Progression and Metastatic Relapse Outcomes in Small Cell Neuroendocrine Carcinomas of the Urinary Tract
Published 2025-01-01Subjects: “…bladder cancer…”
Get full text
Article